Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20181
20193
20201
20211
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto2
AHS Cancer Control Alberta1
Basilea Pharmaceutica1
Elevation Oncology1
Fore Biotherapeutics1
Jazz Pharmaceuticals1
Merck Sharp & Dohme LLC1
Sumitomo Pharma America, Inc.1
Sunnybrook Health Sciences Centre1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Biliary Tract Neoplasms4
Bile Duct Neoplasms3
Carcinoma, Hepatocellular3
Esophageal Neoplasms3
Ovarian Neoplasms3
Urinary Bladder Neoplasms3
Breast Neoplasms2
Colorectal Neoplasms2
Gallbladder Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.